These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10958750)

  • 1. Hypercalciuria and pediatric stone recurrences with and without structural abnormalities.
    Noe HN
    J Urol; 2000 Sep; 164(3 Pt 2):1094-6. PubMed ID: 10958750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High recurrence rate at 5-year followup in children after upper urinary tract stone surgery.
    Lao M; Kogan BA; White MD; Feustel PJ
    J Urol; 2014 Feb; 191(2):440-4. PubMed ID: 24050895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for recurrence in pediatric urinary stone disease.
    Demirtas F; Çakar N; Özçakar ZB; Akıncı A; Burgu B; Yalçınkaya F
    Pediatr Nephrol; 2024 Jul; 39(7):2105-2113. PubMed ID: 38273078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
    Robertson WG; Peacock M
    Nephron; 1980; 26(3):105-10. PubMed ID: 7412965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urolithiasis in geriatric patients.
    Usui Y; Matsuzaki S; Matsushita K; Shima M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):81-7. PubMed ID: 14714833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of calcium stone disease without treatment. What can we expect?
    Strohmaier WL
    Eur Urol; 2000 Mar; 37(3):339-44. PubMed ID: 10720863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis.
    Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J
    J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
    Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
    BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interconversion of stone composition profiles from two recurrent stone episodes in stone formers.
    Zeng G; Zhao Z; Wu W; Ou L; Liang Y; Yuan J
    Clin Chem Lab Med; 2014 Jul; 52(7):1019-24. PubMed ID: 24633751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of stone growth and urinary biochemistry in long-term follow-up of stone patients with idiopathic hypercalciuria.
    Marickar YM; Rose GA
    Br J Urol; 1985 Dec; 57(6):613-7. PubMed ID: 4084717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.
    Robertson WG; Peacock M; Marshall RW; Marshall DH; Nordin BE
    N Engl J Med; 1976 Jan; 294(5):249-52. PubMed ID: 1244550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.